Trials / Recruiting
RecruitingNCT07030400
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
Predictors of Health-Related Quality of Life in Adults With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bruton's tyrosine kinase inhibitor | BTKi |
| DRUG | B-Cell Lymphoma 2 Protein Inhibitor | BCL2i |
Timeline
- Start date
- 2025-07-17
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
- First posted
- 2025-06-22
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07030400. Inclusion in this directory is not an endorsement.